| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.79B | 49.14B | 49.05B | 44.81B | 39.35B | 35.59B |
| Gross Profit | 13.42B | 13.17B | 12.73B | 10.41B | 9.89B | 8.76B |
| EBITDA | 4.88B | 4.90B | 5.15B | 2.81B | 3.13B | 2.28B |
| Net Income | 2.62B | 2.46B | 2.55B | 1.17B | 1.15B | 4.22B |
Balance Sheet | ||||||
| Total Assets | 70.79B | 70.17B | 72.39B | 69.56B | 68.42B | 69.41B |
| Cash, Cash Equivalents and Short-Term Investments | 8.68B | 8.93B | 8.78B | 7.01B | 6.79B | 7.67B |
| Total Debt | 11.25B | 10.69B | 13.73B | 15.28B | 16.71B | 18.52B |
| Total Liabilities | 30.96B | 29.60B | 34.09B | 34.48B | 34.42B | 36.44B |
| Stockholders Equity | 39.05B | 39.84B | 37.62B | 34.46B | 33.41B | 32.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.87B | 3.46B | 1.62B | 1.06B | -792.00M |
| Operating Cash Flow | 0.00 | 4.65B | 4.17B | 2.67B | 2.07B | 2.76B |
| Investing Cash Flow | 0.00 | -815.00M | -580.00M | -821.00M | -917.00M | 3.30B |
| Financing Cash Flow | 0.00 | -3.75B | -1.88B | -1.67B | -2.13B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥38.19B | 17.42 | ― | 3.76% | -2.97% | 18.38% | |
75 Outperform | ¥49.76B | 8.18 | ― | 5.04% | -3.21% | 27.18% | |
75 Outperform | ¥44.92B | 13.60 | ― | 2.97% | 0.89% | -14.25% | |
71 Outperform | ¥50.35B | 45.04 | ― | 5.17% | 3.48% | -6.35% | |
62 Neutral | ¥43.73B | 10.10 | ― | 2.53% | 2.74% | -7.19% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥48.53B | 3.77 | ― | 0.52% | 20.97% | -56.39% |